Australia markets closed

Chugai Pharmaceutical Co., Ltd. (CHGCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
32.43-0.84 (-2.52%)
At close: 03:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in JPY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,111,367,000
1,111,367,000
1,259,726,000
999,758,000
786,946,000
Cost of revenue
413,306,000
413,306,000
476,251,000
338,147,000
273,465,000
Gross profit
698,061,000
698,061,000
783,475,000
661,612,000
513,481,000
Operating expenses
Research development
174,868,000
174,868,000
149,626,000
137,299,000
117,850,000
Selling general and administrative
112,580,000
112,580,000
100,477,000
102,416,000
94,401,000
Total operating expenses
258,887,000
258,887,000
250,167,000
239,715,000
212,251,000
Operating income or loss
439,174,000
439,174,000
533,308,000
421,897,000
301,230,000
Interest expense
27,000
27,000
61,000
48,000
62,000
Income before tax
443,821,000
443,821,000
531,166,000
419,385,000
298,188,000
Income tax expense
118,349,000
118,349,000
156,737,000
116,390,000
83,455,000
Income from continuing operations
325,472,000
325,472,000
374,429,000
302,995,000
214,733,000
Net income
325,472,000
325,472,000
374,429,000
302,995,000
214,733,000
Net income available to common shareholders
325,472,000
325,472,000
374,429,000
302,995,000
214,733,000
Basic EPS
204.69
197.83
227.64
184.29
130.66
Diluted EPS
204.65
197.80
227.57
184.17
130.53
Basic average shares
1,645,174
1,644,798
1,645,209
1,644,121
1,643,445
Diluted average shares
1,645,446
1,645,460
1,645,336
1,645,192
1,645,083